Description
Sermorelin – Advanced Biochemical Mechanism Profile
(GHRH(1-29) analog; Growth Hormone–Releasing Hormone receptor agonist)
Sermorelin is a synthetic 29–amino-acid fragment of endogenous Growth Hormone–Releasing Hormone (GHRH). It selectively activates the GHRH receptor (GHRHR) on pituitary somatotrophs — a Gs-coupled GPCR — driving cAMP accumulation, PKA signaling, Ca²⁺ influx, and GH gene transcription in controlled in-vitro models.
✅ 1. Primary Molecular Target
GHRH Receptor (GHRHR)
-
GPCR coupled to Gsα
-
Activation sequence:
-
Sermorelin binds extracellular GHRHR
-
Gsα → adenylyl cyclase activation
-
↑ cAMP
-
PKA activation
-
Phosphorylation of Ca²⁺ channels & exocytosis machinery
-
Vesicular release of GH from somatotrophs
-
✅ 2. Core Signaling Pathways
A. cAMP → PKA → CREB Pathway (Primary)
-
cAMP elevation triggers PKA
-
PKA phosphorylates CREB
-
CREB binds GH promoter sequences → ↑ GH (GH1) transcription
Representative downstream genes:
-
GH1 (growth hormone)
-
IGF-1 and IGF-1R (secondary axis)
-
GHRHR (autoregulatory feedback)
-
PIT-1 (POU1F1) — pituitary GH transcription factor
B. Ca²⁺ Mobilization
PKA and membrane depolarization enhance:
-
Opening of voltage-gated Ca²⁺ channels
-
ER Ca²⁺ release
-
SNARE-mediated GH exocytosis
Key players:
-
Cav1.2 / Cav1.3
-
Synaptotagmin, SNAP-25, syntaxin (STX-family)
C. MAPK / ERK1/2 Crosstalk
GHRHR activation also recruits:
-
Ras → Raf → MEK → ERK1/2
-
ERK nuclear translocation promotes transcription of:
-
FOS
-
JUN
-
Cell growth and differentiation genes within somatotrophs
-
✅ 3. Enzymatic Pathway Summary
| Pathway | Main Enzyme/Component | Effect |
|---|---|---|
| Adenylyl Cyclase | Gs activation | ↑ cAMP |
| PKA | cAMP-dependent kinase | CREB phosphorylation, Ca²⁺ channel regulation |
| ERK1/2 | MAPK cascade | Mitogenic gene transcription |
| SNARE Complex | Exocytosis proteins | Vesicular GH release |
✅ 4. Second Messengers
| Second Messenger | Mechanistic Role |
|---|---|
| cAMP ↑ | Primary driver of GH transcription and release |
| Ca²⁺ ↑ | Vesicle fusion and exocytosis |
| PKA | Regulation of ion channels & CREB |
| ERK1/2 | Gene expression and somatotroph proliferation |
✅ 5. Representative Gene Targets
| Category | Genes Commonly Monitored in Research |
|---|---|
| GH biosynthesis | GH1, POU1F1 (PIT-1), GHRHR |
| Growth factor axis | IGF-1, IGF-1R |
| Vesicle machinery | SNAP25, SYT1, STXBP1 |
| MAPK response | FOS, JUN, EGR1 |
✅ Mechanistic Summary
-
Sermorelin is a GHRH(1-29) receptor agonist
-
Activates Gs → adenylyl cyclase → cAMP → PKA
-
Triggers Ca²⁺-dependent GH exocytosis
-
Drives CREB-mediated GH gene transcription
-
Engages ERK/MAPK signaling for proliferative and differentiation responses in pituitary models
Research-Only Classification
Sermorelin is supplied solely for controlled in-vitro laboratory research.
Not approved for human or animal administration, therapeutic use, or biological application outside of research environments.
